Amedisys, Inc. (NASDAQ:AMED) Receives Consensus Rating of “Hold” from Analysts

Shares of Amedisys, Inc. (NASDAQ:AMEDGet Free Report) have been assigned a consensus recommendation of “Hold” from the eight research firms that are presently covering the company, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $100.80.

Several analysts recently issued reports on the company. StockNews.com raised Amedisys from a “hold” rating to a “buy” rating in a report on Saturday, May 4th. Raymond James reissued a “market perform” rating on shares of Amedisys in a report on Tuesday, March 26th. Cantor Fitzgerald reissued a “neutral” rating and issued a $101.00 price target on shares of Amedisys in a report on Thursday, April 25th. Finally, Royal Bank of Canada lifted their target price on Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, March 25th.

Read Our Latest Research Report on AMED

Institutional Trading of Amedisys

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Commonwealth Equity Services LLC raised its stake in shares of Amedisys by 2.9% in the 3rd quarter. Commonwealth Equity Services LLC now owns 3,896 shares of the health services provider’s stock worth $364,000 after buying an additional 110 shares in the last quarter. Xponance Inc. raised its stake in shares of Amedisys by 3.2% in the 3rd quarter. Xponance Inc. now owns 4,076 shares of the health services provider’s stock worth $381,000 after buying an additional 125 shares in the last quarter. Retirement Systems of Alabama raised its stake in shares of Amedisys by 0.3% in the 4th quarter. Retirement Systems of Alabama now owns 40,871 shares of the health services provider’s stock worth $3,885,000 after buying an additional 125 shares in the last quarter. Treasurer of the State of North Carolina grew its holdings in shares of Amedisys by 1.0% in the 4th quarter. Treasurer of the State of North Carolina now owns 14,204 shares of the health services provider’s stock worth $1,350,000 after acquiring an additional 140 shares during the last quarter. Finally, Arizona State Retirement System raised its position in shares of Amedisys by 1.5% during the third quarter. Arizona State Retirement System now owns 9,284 shares of the health services provider’s stock worth $867,000 after purchasing an additional 141 shares during the period. Institutional investors own 94.36% of the company’s stock.

Amedisys Price Performance

Shares of AMED opened at $94.08 on Friday. The firm has a market cap of $3.07 billion, a price-to-earnings ratio of -147.00, a PEG ratio of 3.43 and a beta of 0.84. The stock has a 50 day moving average of $92.32 and a 200-day moving average of $93.33. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.31. Amedisys has a 52 week low of $73.10 and a 52 week high of $96.44.

Amedisys (NASDAQ:AMEDGet Free Report) last issued its earnings results on Wednesday, April 24th. The health services provider reported $1.03 EPS for the quarter, topping the consensus estimate of $1.02 by $0.01. The company had revenue of $571.41 million during the quarter, compared to analyst estimates of $565.38 million. Amedisys had a positive return on equity of 12.85% and a negative net margin of 0.91%. The business’s revenue was up 2.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.00 EPS. As a group, analysts forecast that Amedisys will post 4.57 EPS for the current year.

Amedisys Company Profile

(Get Free Report

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Featured Stories

Analyst Recommendations for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.